157 related articles for article (PubMed ID: 11921285)
1. The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues.
Ullmann R; Petzmann S; Klemen H; Fraire AE; Hasleton P; Popper HH
Genes Chromosomes Cancer; 2002 May; 34(1):78-85. PubMed ID: 11921285
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
3. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.
Ullmann R; Schwendel A; Klemen H; Wolf G; Petersen I; Popper HH
Hum Pathol; 1998 Oct; 29(10):1145-9. PubMed ID: 9781656
[TBL] [Abstract][Full Text] [Related]
4. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
[TBL] [Abstract][Full Text] [Related]
5. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.
Walch AK; Zitzelsberger HF; Aubele MM; Mattis AE; Bauchinger M; Candidus S; Präuer HW; Werner M; Höfler H
Am J Pathol; 1998 Oct; 153(4):1089-98. PubMed ID: 9777940
[TBL] [Abstract][Full Text] [Related]
6. Analysis of chromosome-11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridization-based study.
Petzmann S; Ullmann R; Halbwedl I; Popper HH
Virchows Arch; 2004 Aug; 445(2):151-9. PubMed ID: 15235910
[TBL] [Abstract][Full Text] [Related]
7. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors.
Kovatich A; Friedland DM; Druck T; Hadaczek P; Huebner K; Comis RL; Hauck W; McCue PA
Cancer; 1998 Sep; 83(6):1109-17. PubMed ID: 9740075
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity on chromosome arm 11q in lung carcinoids.
Petzmann S; Ullmann R; Klemen H; Renner H; Popper HH
Hum Pathol; 2001 Mar; 32(3):333-8. PubMed ID: 11274644
[TBL] [Abstract][Full Text] [Related]
9. Genetic changes in the spectrum of neuroendocrine lung tumors.
Onuki N; Wistuba II; Travis WD; Virmani AK; Yashima K; Brambilla E; Hasleton P; Gazdar AF
Cancer; 1999 Feb; 85(3):600-7. PubMed ID: 10091733
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.
Kytölä S; Höög A; Nord B; Cedermark B; Frisk T; Larsson C; Kjellman M
Am J Pathol; 2001 May; 158(5):1803-8. PubMed ID: 11337378
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic data helps refining classification of pulmonary carcinoid tumors with increased mitotic counts.
Sazonova O; Manem V; Orain M; Khoshkrood-Mansoori B; Gaudreault N; Desmeules P; Bossé Y; Joubert P
Mod Pathol; 2020 Sep; 33(9):1712-1721. PubMed ID: 32291397
[TBL] [Abstract][Full Text] [Related]
12. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
[TBL] [Abstract][Full Text] [Related]
13. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
[TBL] [Abstract][Full Text] [Related]
14. Carcinomas of the lung with neuroendocrine differentiation.
Carter D; Yesner R
Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas.
Yoshimoto T; Motoi N; Yamamoto N; Nagano H; Ushijima M; Matsuura M; Okumura S; Yamaguchi T; Fukayama M; Ishikawa Y
Neuroendocrinology; 2018; 106(1):47-57. PubMed ID: 28208131
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations of neuroendocrine tumours of the lung.
Rossi G; Bertero L; Marchiò C; Papotti M
Histopathology; 2018 Jan; 72(1):142-152. PubMed ID: 29239031
[TBL] [Abstract][Full Text] [Related]
17. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
Rekhtman N; Desmeules P; Litvak AM; Pietanza MC; Santos-Zabala ML; Ni A; Montecalvo J; Chang JC; Beras A; Preeshagul IR; Sabari JK; Rudin CM; Ladanyi M; Klimstra DS; Travis WD; Lai WC
Mod Pathol; 2019 Jul; 32(8):1106-1122. PubMed ID: 30923345
[TBL] [Abstract][Full Text] [Related]
18. Infrequent mutations of the p53 gene in pulmonary carcinoid tumors.
Lohmann DR; Fesseler B; Pütz B; Reich U; Böhm J; Präuer H; Wünsch PH; Höfler H
Cancer Res; 1993 Dec; 53(23):5797-801. PubMed ID: 8242638
[TBL] [Abstract][Full Text] [Related]
19. Expression of developing neural transcription factors in lung carcinoid tumors.
Endo T; Yazawa T; Shishido-Hara Y; Fujiwara M; Shimoyamada H; Ishii J; Sato H; Tachibana K; Takei H; Kondo H; Goya T; Endo S; Kamma H
Pathol Int; 2014 Aug; 64(8):365-74. PubMed ID: 25143124
[TBL] [Abstract][Full Text] [Related]
20. 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice.
Finkelstein SD; Hasegawa T; Colby T; Yousem SA
Am J Pathol; 1999 Aug; 155(2):633-40. PubMed ID: 10433956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]